Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leaving child and adolescent mental health services in the MILESTONE cohort: a longitudinal cohort study on young people's mental health indicators, care pathways, and outcomes in Europe.
Gerritsen SE, van Bodegom LS, Overbeek MM, Maras A, Verhulst FC, Wolke D, Rizopoulos D, de Girolamo G, Franić T, Madan J, McNicholas F, Paul M, Purper-Ouakil D, Santosh PJ, Schulze UME, Singh SP, Street C, Tremmery S, Tuomainen H, Dieleman GC; MILESTONE consortium. Gerritsen SE, et al. Among authors: santosh pj. Lancet Psychiatry. 2022 Dec;9(12):944-956. doi: 10.1016/S2215-0366(22)00310-8. Lancet Psychiatry. 2022. PMID: 36403599
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications].
Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E. Banaschewski T, et al. Z Kinder Jugendpsychiatr Psychother. 2008 Mar;36(2):97-106; quiz 106-7. doi: 10.1024/1422-4917.36.2.97. Z Kinder Jugendpsychiatr Psychother. 2008. PMID: 18622939 Free article. Review. German.
A neural systems approach in autism spectrum disorders.
Santosh PJ. Santosh PJ. Dev Med Child Neurol. 2012 Mar;54(3):206-7. doi: 10.1111/j.1469-8749.2012.04222.x. Dev Med Child Neurol. 2012. PMID: 22324642 Free article. No abstract available.
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology.
Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, Heal D, Müller U, Nash J, Santosh P, Sayal K, Sonuga-Barke E, Young SJ; British Association for Psychopharmacology. Bolea-Alamañac B, et al. J Psychopharmacol. 2014 Mar;28(3):179-203. doi: 10.1177/0269881113519509. Epub 2014 Feb 12. J Psychopharmacol. 2014. PMID: 24526134
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations].
Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E. Banaschewski T, et al. Z Kinder Jugendpsychiatr Psychother. 2008 Mar;36(2):81-94; quiz 94-5. doi: 10.1024/1422-4917.36.2.81. Z Kinder Jugendpsychiatr Psychother. 2008. PMID: 18622938 Review. German.
Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study.
Remschmidt H, Hoare P, Ettrich C, Rothenberger A, Santosh P, Schmidt M, Spender Q, Tamhne R, Thompson M, Tinline C, Trott GE, Medori R. Remschmidt H, et al. Eur Child Adolesc Psychiatry. 2005 Sep;14(6):297-304. doi: 10.1007/s00787-005-0467-6. Eur Child Adolesc Psychiatry. 2005. PMID: 16220213 Clinical Trial.
130 results